T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
UNICANCER
Masonic Cancer Center, University of Minnesota
Alliance for Clinical Trials in Oncology
Baylor College of Medicine
University of Chicago
University of Rochester
National Institutes of Health Clinical Center (CC)
Northside Hospital, Inc.